COVID-19 and Venous Thromboembolism Risk
Completed
Conditions studied: Venous Thromboembolism, Covid19
In brief
Coronavirus disease 2019 (Covid-19) is now a leading cause of death among U.S. adults. In addition to profound respiratory and multi-organ failure, hypercoagulable states and venous thromboembolism (VTE) have been increasingly reported in patients with severe Covid-19. The aim of this study is evaluate the risk of VTE related to Covid-19 infection in a real-world community-based population.
Key facts
- Study ID
- NCT04569344
- Run by
- University of California, San Francisco
- People needed
- 398530
- Starts
- 2020-01-01
- Expected to finish
- 2022-06-21
- Last updated by the study team
- 2022-11-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Kaiser Permanente Northern California — Oakland, California, United States
- Kaiser Permanente Southern California — Pasadena, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.